Rad51 Promoter-Targeted Gene Therapy Is Effective for In Vivo Visualization and Treatment of Cancer.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 347, doi. 10.1038/mt.2011.215
- By:
- Publication type:
- Article
Works matching IS 15250016 AND DT 2012 AND VI 20 AND IP 2
Results: 31
1
2
Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?
- Published in:
- 2012
- By:
- Publication type:
- Opinion
3
Safety and Feasibility of High-pressure Transvenous Limb Perfusion With 0.9% Saline in Human Muscular Dystrophy.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 456, doi. 10.1038/mt.2011.137
- By:
- Publication type:
- Article
4
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 443, doi. 10.1038/mt.2011.237
- By:
- Publication type:
- Article
5
Cell-Penetrating RNAs: New Keys to the Castle.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
6
Rapidly Regulating Platelet Activity In Vivo With an Antidote Controlled Platelet Inhibitor.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 391, doi. 10.1038/mt.2011.226
- By:
- Publication type:
- Article
7
Signs of Progress in Gene Therapy for Muscular Dystrophy Also Warrant Caution.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
8
Atelocollagen-mediated Systemic Delivery Prevents Immunostimulatory Adverse Effects of siRNA in Mammals.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 356, doi. 10.1038/mt.2011.221
- By:
- Publication type:
- Article
9
AAV Transduction of Dopamine Neurons With Constitutively Active Rheb Protects From Neurodegeneration and Mediates Axon Regrowth.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 275, doi. 10.1038/mt.2011.213
- By:
- Publication type:
- Article
10
Quantitative 3D Tracing of Gene-delivery Viral Vectors in Human Cells and Animal Tissues.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 317, doi. 10.1038/mt.2011.250
- By:
- Publication type:
- Article
11
Corrigendum to 'Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors'.
- Published in:
- 2012
- Publication type:
- Correction Notice
12
Corrigendum to 'Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects'.
- Published in:
- 2012
- Publication type:
- Correction Notice
13
Preclinical Dose-Finding Study With a Liver-Tropic, Recombinant AAV-2/8 Vector in the Mouse Model of Galactosialidosis.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 267, doi. 10.1038/mt.2011.227
- By:
- Publication type:
- Article
14
Genetic Targeting of the Active Transcription Factor XBP1s to Dendritic Cells Potentiates Vaccine-induced Prophylactic and Therapeutic Antitumor Immunity.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 432, doi. 10.1038/mt.2011.183
- By:
- Publication type:
- Article
15
Construction of an Oncolytic Herpes Simplex Virus That Precisely Targets Hepatocellular Carcinoma Cells.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 339, doi. 10.1038/mt.2011.265
- By:
- Publication type:
- Article
16
In This Issue.
- Published in:
- 2012
- Publication type:
- Abstract
17
PCSK9 LNA Antisense Oligonucleotides Induce Sustained Reduction of LDL Cholesterol in Nonhuman Primates.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 376, doi. 10.1038/mt.2011.260
- By:
- Publication type:
- Article
18
Oncolytic Sindbis Virus Targets Tumors Defective in the Interferon Response and Induces Significant Bystander Antitumor Immunity In Vivo.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 298, doi. 10.1038/mt.2011.245
- By:
- Publication type:
- Article
19
Directed Evolution of Adeno-associated Virus for Enhanced Gene Delivery and Gene Targeting in Human Pluripotent Stem Cells.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 329, doi. 10.1038/mt.2011.255
- By:
- Publication type:
- Article
20
Efficient and Accurate Homologous Recombination in hESCs and hiPSCs Using Helper-dependent Adenoviral Vectors.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 424, doi. 10.1038/mt.2011.266
- By:
- Publication type:
- Article
21
Research Highlights.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 245, doi. 10.1038/mt.2011.297
- Publication type:
- Article
22
Functionally Enhanced siRNA Targeting TNFα Attenuates DSS-induced Colitis and TLR-mediated Immunostimulation in Mice.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 382, doi. 10.1038/mt.2011.236
- By:
- Publication type:
- Article
23
RNAi Targeting CXCR4 Inhibits Tumor Growth Through Inducing Cell Cycle Arrest and Apoptosis.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 398, doi. 10.1038/mt.2011.257
- By:
- Publication type:
- Article
24
Personalized Medicine: Words That Mean Just What You Choose?
- Published in:
- 2012
- By:
- Publication type:
- Editorial
25
Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and 'Vstat120'-expressing Oncolytic Virus.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 287, doi. 10.1038/mt.2011.208
- By:
- Publication type:
- Article
26
Mesenchymal Stromal Cells Protect Cancer Cells From ROS-induced Apoptosis and Enhance the Warburg Effect by Secreting STC1.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 417, doi. 10.1038/mt.2011.259
- By:
- Publication type:
- Article
27
In Vivo Delivery of Cytoplasmic RNA Virus-derived miRNAs.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 367, doi. 10.1038/mt.2011.244
- By:
- Publication type:
- Article
28
Efficient Reprogramming of Human Cord Blood CD34<sup>+</sup> Cells Into Induced Pluripotent Stem Cells With OCT4 and SOX2 Alone.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 408, doi. 10.1038/mt.2011.258
- By:
- Publication type:
- Article
29
Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 462, doi. 10.1038/mt.2011.248
- By:
- Publication type:
- Article
30
Liver Production of Sulfamidase Reverses Peripheral and Ameliorates CNS Pathology in Mucopolysaccharidosis IIIA Mice.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 254, doi. 10.1038/mt.2011.220
- By:
- Publication type:
- Article
31
Modification of the Early Gene Enhancer-promoter Improves the Oncolytic Potency of Adenovirus 11.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 2, p. 306, doi. 10.1038/mt.2011.242
- By:
- Publication type:
- Article